Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 869592Generated: October 27, 2026

(E)-2-[8-(bromomethyl)-3-fluorodibenzo[b,e]oxepin-11(6H)-ylidene]propanenitrile → (E)-2-{8-[(2-cyclopropyl-1H-thieno[3,4-d]imidazol-1-yl)methyl]-3-fluorodibenzo[b,e]oxepin-11(6H)-ylidene}propanenitrile

https://huagongshe.com/reaction/869592

Reaction equation

Participants

RoleNameHCIDCharge
Reactant(E)-2-[8-(bromomethyl)-3-fluorodibenzo[b,e]oxepin-11(6H)-ylidene]propanenitrileHCID 86721333—
Reactant2-cyclopropyl-1H-thieno[3,4-d]imidazoleHCID 86721442—
Product(E)-2-{8-[(2-cyclopropyl-1H-thieno[3,4-d]imidazol-1-yl)methyl]-3-fluorodibenzo[b,e]oxepin-11(6H)-ylidene}propanenitrileHCID 8672144395%

Reaction Steps

[step 2] Using 2-cyclopropyl-1H-thieno[3,4-d]imidazole (65 mg, 0.40 mmol) obtained in step 1 and (E)-2-[8-(bromomethyl)-3-fluorodibenzo[b,e]oxepin-11(6H)-ylidene]propanenitrile (145 mg, 0.40 mmol) obtained in Reference Example 1, and in the same manner as in Reference Example 1A, the title compound (166 mg, 95%) was obtained.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08969345B2
Source datasetuspto-grants-2015_03
ORD IDord-63ae5dc8b2af4f82b9ccff4e04b75e7e
Source noteuspto-grants-2015_03